Amy Jenkins joined Eli Lilly & Company in 2004 with over 12 years of clinical experience as an Acute Care Nurse Practitioner and now has more than 20 years in the pharmaceutical industry. Throughout her tenure, Amy has held various roles in medical and investigator engagement, including Clinical Development Liaison and Medical Science Liaison, significantly contributing to site and patient relationships in clinical trials. Currently, Amy is instrumental in overseeing clinical trial operations in the investigator optimization role. She provides operational oversight, supports feasibility, site selection, site performance, and data quality. Amy has extensive expertise in decentralized clinical trial (DCT) design and has worked across multiple therapeutic areas, including Rheumatology, Critical Care Medicine, Cardiology, Dermatology, Diabetes, Immunology, Neurology, Gastroenterology, and Infectious Disease. Amy and her team prioritize investigator, site, and patient relationships to conduct efficient and effective clinical trials, enhancing recruitment, retention, and diversity, ultimately improving clinical trial experiences. Amy holds a Master of Science in Nursing from Indiana University and a Bachelor of Science in Nursing from Purdue University.
